中文

DMC

₫57,500
+0.00% 2026-09-15 · Close
AI Composite Signal
6.4 / 10
Neutral — 5-signal composite
Mkt Cap
2.0T
₫2.0T
P/E
9.9
P/B
1.2
ROE
11.7%
ROA
10.5%
EPS
5.9K
Price Chart
What matters now

DMC (DMC) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 57,500 VND, little changed on the session, giving a market capitalization of 2.0 trillion VND.

On valuation, DMC trades at a price-to-earnings ratio of 9.9 and a price-to-book of 1.2. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 11.7% points to modest profitability relative to the company's equity base. Trailing earnings per share stand at 5,872 VND.

Aveluro tracks 9 news items mentioning DMC. The most recent catalyst was a dividend announcement event — "DMC Announces 25% Cash Dividend for 2025, Record Date Sept 15". Aveluro's composite model rates DMC 6.4/10 (Neutral), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Latest catalyst

DMC Announces 25% Cash Dividend for 2025, Record Date Sept 15

Recent Developments

Recent developments around DMC include 5 notable classified events. On Aug 24, 2026, a dividend announcement was reported: Domesco (DMC) will pay a 25% cash dividend for 2025, equivalent to 2,500 VND per share, with payment on October 21 and a record date of September 15. On Aug 24, 2026, a dividend announcement was reported: DMC (HOSE) declares a 25% cash dividend for 2025, payable October 21, 2026, with record date September 15, 2025. On Aug 13, 2026, a market event was reported: SCIC's 2026-2030 restructuring plan targets full divestment from 66 enterprises, potentially adding significant supply to the market, while retaining stakes in 21 firms including Vinamilk (VNM), Sabeco (SAB), and FPT. On Aug 13, 2026, a macro policy event was reported: KBSV identifies 13 companies in the state divestment pipeline under Decision 40, with notable planned reductions at BCM, BSR, and GAS, and full divestment for MSB, NTP, HND, QTP, VGC, PVI, and DMC. On May 13, 2026, a market event was reported: Vietnam's top three pharma companies by market cap—DHG, IMP, and DHT—are now under foreign control or significant influence, with Taisho, Livzon, and ASKA as key shareholders.

The overall tone of recent coverage is positive, with 2 of 5 events carrying bullish sentiment.

AI Signal Breakdown
Bearish Neutral Bullish
6.4 / 10
Neutral
Sentiment
+0.00
Impact
0.50
Momentum
-0.38
Fundamentals
+0.70
Volume
0.00
Sentiment 30% · Impact 20% · Momentum 20% · Fundamentals 15% · Volume 15%
News Sentiment
9
Articles Analyzed
Neutral 5
Positive 4
Recent News
Aug 24, 2026 Full Analysis Positive dividend announcement
Domesco (DMC) will pay a 25% cash dividend for 2025, equivalent to 2,500 VND per share, with payment on October 21 and a record date of September 15. The payout totals nearly 86.8 billion VND, with major shareholders Abbott and SCIC receiving the bulk.
Aug 24, 2026 Full Analysis Positive dividend announcement
DMC (HOSE) declares a 25% cash dividend for 2025, payable October 21, 2026, with record date September 15, 2025. Abbott Laboratories (Chile) Holdco Spa, holding 51.69%, will receive about VND 45 billion.
Aug 13, 2026 Full Analysis Neutral stake change
SCIC's 2026-2030 restructuring plan targets full divestment from 66 enterprises, potentially adding significant supply to the market, while retaining stakes in 21 firms including Vinamilk (VNM), Sabeco (SAB), and FPT. The list is flexible, so actual divestment pace will vary by company and market conditions.
Aug 13, 2026 Full Analysis Neutral macro policy
KBSV identifies 13 companies in the state divestment pipeline under Decision 40, with notable planned reductions at BCM, BSR, and GAS, and full divestment for MSB, NTP, HND, QTP, VGC, PVI, and DMC. The market-wide impact is expected to be limited, but individual tickers may see volatility as ownership changes unfold.
May 13, 2026 Full Analysis Neutral sector sentiment
Vietnam's top three pharma companies by market cap—DHG, IMP, and DHT—are now under foreign control or significant influence, with Taisho, Livzon, and ASKA as key shareholders. The sector is projected to double from $8-9 billion to $16 billion by 2032, driving M&A interest.
Apr 20, 2026 Full Analysis Positive earnings beat
VNDirect (VND) posted Q1 2026 pre-tax profit of VND 681 billion, a 43% year-on-year increase, as part of a broader earnings release wave. TP Securities (ORS) led with a 1,961% surge to VND 42 billion, while ACBS grew 67% to VND 303 billion, highlighting divergent performance in Vietnam's securities sector amid mixed market conditions.
Full Analysis Neutral m a announcement
IMP is now majority-owned by China's Livzon after a VND 6,000B deal for 67.87% of shares. The acquisition gives Livzon control of IMP's 12 EU-GMP production lines, a rare asset in Vietnam.
Related Stocks — Health Care
Stock Analysis

By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-09-15T16:36:19Z.